266 related articles for article (PubMed ID: 25169167)
1. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study.
Willeit P; Kiechl S; Kronenberg F; Witztum JL; Santer P; Mayr M; Xu Q; Mayr A; Willeit J; Tsimikas S
J Am Coll Cardiol; 2014 Sep; 64(9):851-60. PubMed ID: 25169167
[TBL] [Abstract][Full Text] [Related]
2. Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events.
Tsimikas S; Willeit P; Willeit J; Santer P; Mayr M; Xu Q; Mayr A; Witztum JL; Kiechl S
J Am Coll Cardiol; 2012 Nov; 60(21):2218-29. PubMed ID: 23122790
[TBL] [Abstract][Full Text] [Related]
3. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.
Zhao Y; Delaney JA; Quek RG; Gardin JM; Hirsch CH; Gandra SR; Wong ND
Clin Cardiol; 2016 Jul; 39(7):413-20. PubMed ID: 27177347
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium.
Waldeyer C; Makarova N; Zeller T; Schnabel RB; Brunner FJ; Jørgensen T; Linneberg A; Niiranen T; Salomaa V; Jousilahti P; Yarnell J; Ferrario MM; Veronesi G; Brambilla P; Signorini SG; Iacoviello L; Costanzo S; Giampaoli S; Palmieri L; Meisinger C; Thorand B; Kee F; Koenig W; Ojeda F; Kontto J; Landmesser U; Kuulasmaa K; Blankenberg S
Eur Heart J; 2017 Aug; 38(32):2490-2498. PubMed ID: 28449027
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.
Naka KK; Bechlioullis A; Marini A; Sionis D; Vakalis K; Triantis G; Wilkins L; Rogus J; Kornman KS; Witztum JL; Doucette-Stamm L; Michalis LK; Tsimikas S
J Clin Lipidol; 2018; 12(2):338-347. PubMed ID: 29310992
[TBL] [Abstract][Full Text] [Related]
7. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
Perrot N; Verbeek R; Sandhu M; Boekholdt SM; Hovingh GK; Wareham NJ; Khaw KT; Arsenault BJ
Atherosclerosis; 2017 Jan; 256():47-52. PubMed ID: 27998826
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis.
Yeboah J; Carr JJ; Terry JG; Ding J; Zeb I; Liu S; Nasir K; Post W; Blumenthal RS; Budoff MJ
Eur J Prev Cardiol; 2014 Oct; 21(10):1233-41. PubMed ID: 23689526
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.
Cook NR; Mora S; Ridker PM
J Am Coll Cardiol; 2018 Jul; 72(3):287-296. PubMed ID: 30012322
[TBL] [Abstract][Full Text] [Related]
10. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.
Virani SS; Brautbar A; Davis BC; Nambi V; Hoogeveen RC; Sharrett AR; Coresh J; Mosley TH; Morrisett JD; Catellier DJ; Folsom AR; Boerwinkle E; Ballantyne CM
Circulation; 2012 Jan; 125(2):241-9. PubMed ID: 22128224
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
Tsimikas S; Willeit J; Knoflach M; Mayr M; Egger G; Notdurfter M; Witztum JL; Wiedermann CJ; Xu Q; Kiechl S
Eur Heart J; 2009 Jan; 30(1):107-15. PubMed ID: 19019993
[TBL] [Abstract][Full Text] [Related]
12. Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia.
Cao YX; Jin JL; Guo YL; Sun D; Liu HH; Wu NQ; Xu RX; Zhu CG; Liu G; Dong Q; Sun J; Li JJ
Atherosclerosis; 2019 Dec; 291():27-33. PubMed ID: 31683090
[TBL] [Abstract][Full Text] [Related]
13. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.
Ridker PM; Paynter NP; Rifai N; Gaziano JM; Cook NR
Circulation; 2008 Nov; 118(22):2243-51, 4p following 2251. PubMed ID: 18997194
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.
Suk Danik J; Rifai N; Buring JE; Ridker PM
J Am Coll Cardiol; 2008 Jul; 52(2):124-31. PubMed ID: 18598891
[TBL] [Abstract][Full Text] [Related]
16. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis.
Bhatia HS; Rikhi R; Allen TS; Yeang C; Guan W; Garg PK; Tsai MY; Criqui MH; Shapiro MD; Tsimikas S
Atherosclerosis; 2023 Sep; 381():117217. PubMed ID: 37607461
[TBL] [Abstract][Full Text] [Related]
18. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
